More Books:

Antiangiogenic Agents in Cancer Therapy
Language: en
Pages: 559
Authors: Beverly A. Teicher, Lee M. Ellis
Categories: Medical
Type: BOOK - Published: 2008-01-08 - Publisher: Springer Science & Business Media

This volume represents a compendium of scientific findings and approaches to the study of angiogenesis in cancer. The second edition of Antiangiogenic Agents in Cancer Therapy is intended to give a current perspective on the state-of-the-art of angiogenensis and therapy directed at this process. Antiangiogenesis is a dynamic and evolving
Antiangiogenic Agents in Cancer Therapy
Language: en
Pages: 470
Authors: Beverly A. Teicher
Categories: Medical
Type: BOOK - Published: 2014-01-15 - Publisher:

Books about Antiangiogenic Agents in Cancer Therapy
Mechanistic Study of Antiangiogenic Agents in Cancer Therapy
Language: en
Pages: 45
Authors: Beverly A. Teicher
Categories: Medical
Type: BOOK - Published: 2013 - Publisher:

Books about Mechanistic Study of Antiangiogenic Agents in Cancer Therapy
Anti-angiogenic Drugs as Chemosensitizers in Cancer Therapy
Language: en
Pages: 400
Authors: Beverly A. Teicher
Categories: Science
Type: BOOK - Published: 2022-01-15 - Publisher: Academic Press

Anti-angiogenic Drugs as Chemosensitizers in Cancer Therapy presents updated reviews on anti-angiogenic drugs used in tumor therapy. It focuses on the use of anti-angiogenic drugs as sensitizers of tumor cells to the inhibitory activity of antitumor agents. Conventional and novel anti-neoplastic agents (cytotoxic molecules, hormones/antihormones, immunotherapies) are taken in consideration
Anti-Angiogenesis Strategies in Cancer Therapies
Language: en
Pages: 210
Authors: Shaker Mousa, Paul Davis
Categories: Medical
Type: BOOK - Published: 2016-11-28 - Publisher: Academic Press

Anti-angiogenesis Strategies in Cancer Therapeutics provides a detailed look at the current status and future directions in the discovery and development of novel anti-angiogenesis strategies in oncology. This book highlights the different mechanisms involved in the modulation of angiogenesis, including inflammation, thrombosis, and microRNA, and shows how nanotechnology can further